These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
262 related articles for article (PubMed ID: 29419571)
1. Ameliorative Effect of Epigallocatechin Gallate on Cardiac Hypertrophy and Fibrosis in Aged Rats. Muhammed I; Sankar S; Govindaraj S J Cardiovasc Pharmacol; 2018 Feb; 71(2):65-75. PubMed ID: 29419571 [TBL] [Abstract][Full Text] [Related]
2. Epigallocatechin-3-gallate attenuates cardiac hypertrophy in hypertensive rats in part by modulation of mitogen-activated protein kinase signals. Chen DD; Dong YG; Liu D; He JG Clin Exp Pharmacol Physiol; 2009 Sep; 36(9):925-32. PubMed ID: 19298531 [TBL] [Abstract][Full Text] [Related]
3. (-)-Epigallocatechin-3-gallate suppresses cigarette smoke-induced inflammation in human cardiomyocytes via ROS-mediated MAPK and NF-κB pathways. Liang Y; Ip MSM; Mak JCW Phytomedicine; 2019 May; 58():152768. PubMed ID: 31005721 [TBL] [Abstract][Full Text] [Related]
4. Antioxidant effects of hydrogen sulfide on left ventricular remodeling in smoking rats are mediated via PI3K/Akt-dependent activation of Nrf2. Zhou X; Zhao L; Mao J; Huang J; Chen J Toxicol Sci; 2015 Mar; 144(1):197-203. PubMed ID: 25516494 [TBL] [Abstract][Full Text] [Related]
6. Epigallocatechin-3-gallate augments antioxidant activities and inhibits inflammation during bleomycin-induced experimental pulmonary fibrosis through Nrf2-Keap1 signaling. Sriram N; Kalayarasan S; Sudhandiran G Pulm Pharmacol Ther; 2009 Jun; 22(3):221-36. PubMed ID: 19138753 [TBL] [Abstract][Full Text] [Related]
7. Epigallocathechin-3 gallate inhibits cardiac hypertrophy through blocking reactive oxidative species-dependent and -independent signal pathways. Li HL; Huang Y; Zhang CN; Liu G; Wei YS; Wang AB; Liu YQ; Hui RT; Wei C; Williams GM; Liu DP; Liang CC Free Radic Biol Med; 2006 May; 40(10):1756-75. PubMed ID: 16767845 [TBL] [Abstract][Full Text] [Related]
8. Neohesperidin inhibits cardiac remodeling induced by Ang II in vivo and in vitro. Zhang J; Fu X; Yang L; Wen H; Zhang L; Liu F; Lou Y; Yang Q; Ding Y Biomed Pharmacother; 2020 Sep; 129():110364. PubMed ID: 32531678 [TBL] [Abstract][Full Text] [Related]
9. Puerarin inhibits angiotensin II-induced cardiac hypertrophy via the redox-sensitive ERK1/2, p38 and NF-κB pathways. Chen G; Pan SQ; Shen C; Pan SF; Zhang XM; He QY Acta Pharmacol Sin; 2014 Apr; 35(4):463-75. PubMed ID: 24608673 [TBL] [Abstract][Full Text] [Related]
10. Hemin decreases cardiac oxidative stress and fibrosis in a rat model of systemic hypertension via PI3K/Akt signalling. Worou ME; Belmokhtar K; Bonnet P; Vourc'h P; Machet MC; Khamis G; Eder V Cardiovasc Res; 2011 Jul; 91(2):320-9. PubMed ID: 21406596 [TBL] [Abstract][Full Text] [Related]
11. Attenuation of liver ischemia/reperfusion induced apoptosis by epigallocatechin-3-gallate via down-regulation of NF-kappaB and c-Jun expression. Giakoustidis DE; Giakoustidis AE; Iliadis S; Koliakou K; Antoniadis N; Kontos N; Papanikolaou V; Papageorgiou G; Kaldrimidou E; Takoudas D J Surg Res; 2010 Apr; 159(2):720-8. PubMed ID: 19394642 [TBL] [Abstract][Full Text] [Related]
12. Baicalein attenuates angiotensin II-induced cardiac remodeling via inhibition of AKT/mTOR, ERK1/2, NF-κB, and calcineurin signaling pathways in mice. Wang AW; Song L; Miao J; Wang HX; Tian C; Jiang X; Han QY; Yu L; Liu Y; Du J; Xia YL; Li HH Am J Hypertens; 2015 Apr; 28(4):518-26. PubMed ID: 25362112 [TBL] [Abstract][Full Text] [Related]
13. Epigallocatechin-3-Gallate Attenuates Adriamycin-Induced Focal Segmental Glomerulosclerosis via Suppression of Oxidant Stress and Apoptosis by Targeting Hypoxia-Inducible Factor-1α/ Angiopoietin-Like 4 Pathway. Liu G; He L Pharmacology; 2019; 103(5-6):303-314. PubMed ID: 30840953 [TBL] [Abstract][Full Text] [Related]
14. Cardioprotective effects of epigallocatechin-3-gallate against doxorubicin-induced cardiomyocyte injury. Zheng J; Lee HC; Bin Sattar MM; Huang Y; Bian JS Eur J Pharmacol; 2011 Feb; 652(1-3):82-8. PubMed ID: 21114975 [TBL] [Abstract][Full Text] [Related]
15. Low molecular weight fucoidan alleviates cardiac dysfunction in diabetic Goto-Kakizaki rats by reducing oxidative stress and cardiomyocyte apoptosis. Yu X; Zhang Q; Cui W; Zeng Z; Yang W; Zhang C; Zhao H; Gao W; Wang X; Luo D J Diabetes Res; 2014; 2014():420929. PubMed ID: 25525607 [TBL] [Abstract][Full Text] [Related]
16. The Nuclear Factor kappaB Inhibitor Pyrrolidine Dithiocarbamate Prevents Cardiac Remodelling and Matrix Metalloproteinase-2 Up-Regulation in Renovascular Hypertension. Cau SB; Guimaraes DA; Rizzi E; Ceron CS; Gerlach RF; Tanus-Santos JE Basic Clin Pharmacol Toxicol; 2015 Oct; 117(4):234-41. PubMed ID: 25816715 [TBL] [Abstract][Full Text] [Related]